IL1B and prostate carcinoma: Karan et al. reported that increased expression of NLRP12 in prostate cancer shows that it might play a crucial role in activating the NF-κB and IL-1β signalling pathways and that it might be associated with the occurrence and progression of prostate cancer [26].